	US 12,186,340 B2
	Synthetic antimicrobial mineral compositions, methods of making and using same
Keith David Morrison, Livermore, CA (US); Gabriela G. Loots, Oakland, CA (US); Ty James Samo, Walnut Creek, CA (US); and Kelly Anne Martin, Dublin, CA (US)
Assigned to LAWRENCE LIVERMORE NATIONAL SECURITY, LLC, Livermore, CA (US)
Filed by LAWRENCE LIVERMORE NATIONAL SECURITY, LLC, Livermore, CA (US)
Filed on Jun. 25, 2021, as Appl. No. 17/358,929.
Claims priority of provisional application 63/044,639, filed on Jun. 26, 2020.
Prior Publication US 2022/0000912 A1, Jan. 6, 2022
Int. Cl. A61K 33/26 (2006.01); A61L 15/18 (2006.01); A61L 15/44 (2006.01); B33Y 70/10 (2020.01); B33Y 80/00 (2015.01); C08L 83/04 (2006.01)

CPC A61K 33/26 (2013.01) [A61L 15/18 (2013.01); A61L 15/44 (2013.01); B33Y 70/10 (2020.01); B33Y 80/00 (2014.12); C08L 83/04 (2013.01)]

21 Claims

1. A pharmaceutical composition comprising Fe²⁺-exchanged fluorinated synthetic smectite and synthetic semiconducting metal sulfide, wherein the Fe²⁺-exchanged fluorinated synthetic smectite comprises interlayer Fe²⁺, and when administered the interlayer Fe²⁺ is released from interlayer spaces of the Fe²⁺-exchanged fluorinated synthetic smectite.